Heart Failure
Heart Failure
Advertisement
Rob DillardHeart Failure | June 12, 2025
Patients experienced a median 57.6-month delay from first symptoms to ATTR-CM diagnosis, study finds.
Read More
CardioNerdsHeart Failure | June 12, 2025
MITT and safety data show acoramidis significantly lowers AFib-related events in transthyretin cardiac amyloidosis.
Amit Goyal, MDInterventional Cardiology | June 11, 2025
LuX-Valve offers a safe, effective option for severe TR patients at high surgical risk.
CardioNerdsHeart Failure Congress 2025 | June 5, 2025
ESC 2025: Acoramidis may reduce AF/flutter burden in ATTR-CM, per new ATTRibute-CM trial analysis discussed by CardioNerds.
Rob DillardHeart Failure Congress 2025 | June 5, 2025
PVR severity is linked to higher short-term mortality in HFrEF, highlighting its role in risk stratification.
Nsisong Asanga, PhDHeart Failure | June 3, 2025
IMPLEMENT-HF raised heart failure quad therapy use from 4.7% to 44.6% at discharge and 0% to 44.8% at 30 days.
Nsisong Asanga, PhDHeart Failure | May 30, 2025
Experts call for better trials and teamwork to advance transcatheter valve treatment for heart failure-related valve disease.
Mark GoddardHeart Failure | May 23, 2025
AI-driven ECGs are transforming heart failure care—enabling early detection, cutting costs, and expanding access.
Rob DillardHeart Failure Congress 2025 | May 20, 2025
Checklist use for ATTR-CM "red flags" boosted diagnosis rates up to 10x in heart failure patients, study finds.
Rob DillardHeart Failure Congress 2025 | May 20, 2025
Heart failure affects over 640,000 kids and teens globally—urgent prevention and care policies are needed, study finds.
Rob DillardHeart Failure Congress 2025 | May 20, 2025
Waist-to-height ratio may better predict heart failure risk than BMI, new Heart Failure 2025 study finds.
Rob DillardHeart Failure Congress 2025 | May 20, 2025
Acoramidis rapidly boosts serum TTR levels in ATTR-CM patients, with effects sustained through 30 months, study shows.
CardioNerdsCardioNerds | May 15, 2025
Explore evolving LV unloading strategies in AMI shock with The CardioNerds.
CardioNerdsCardioNerds | May 15, 2025
Pulmonary air embolism causing RV failure & arrest—via ocular route? A rare case, deep dive, with The CardioNerds.
Jordana JampelAtrial Fibrillation | May 13, 2025
The presence of a CMP-PLP variant was linked to a 1.6-fold increased risk for cardiomyopathy or heart failure.
CardioNerdsCardioNerds | May 12, 2025
Dr. Daniel Judge discusses how the ATTRibute-CM trial marks a turning point in ATTR cardiomyopathy treatment and research.
CardioNerdsCardioNerds | May 2, 2025
Dr. Dan Judge speaks to The CardioNerds about his interpretation of the primary findings from ATTRibute-CM.
CardioNerdsCardioNerds | May 5, 2025
Dr. Daniel Judge talks to the CardioNerds about a pivotal study in ATTR-CM.
Rob DillardACC.25: Focus on ATTR-CM | April 30, 2025
A multifaceted approach is necessary to reduce the deaths of smoking-related aortic aneurysms.
Rob DillardACC.25: Focus on ATTR-CM | April 29, 2025
Many preschool-aged children with congenital heart conditions are not on track for school readiness.
Advertisement
Advertisement